Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
62%
Asthma
38%
Small Cell Lung Cancer
35%
Cancer-Related Fatigue
35%
Heart Rate Variability
35%
Medicine
35%
Alternative Complement Pathway C3 C5 Convertase
26%
Nuclear Factor
26%
Exercise
22%
Disease
21%
Tumor Necrosis Factor
21%
Observational Study
17%
Drug Sensitivity
17%
Granulomatosis with Polyangiitis
17%
Ex Vivo
17%
Microsphere
17%
Mucosa
17%
Disease Course
17%
Bronchiectasis
17%
Negative Pressure Ventilation
17%
Circulating Tumor Cell
17%
Interstitial Collagenase
17%
Response Evaluation Criteria in Solid Tumors
17%
Sepsis
17%
Disease Severity
17%
Multiple Organ Dysfunction Syndrome
17%
Pulmonary Rehabilitation
17%
Cystic Fibrosis
17%
Emphysema
17%
4 Iodo 2,5 Dimethoxyamphetamine
17%
Health Care Cost
17%
Nucleic Acid Amplification
17%
Chronic Cough
17%
Obstructive Sleep Apnea
17%
Lung Adenocarcinoma
17%
Histone Acetylation
17%
Epidermal Growth Factor Receptor
17%
Neutrophil
17%
Systematic Review
17%
Meta-Analysis
17%
Cardiopulmonary Exercise Test
17%
Hand-Schüller-Christian Disease
17%
Diagnostic Accuracy
17%
Respiratory Disease
17%
Interferon
17%
Chemokine
17%
Ciclesonide
17%
Drug Megadose
17%
Epithelial Cell
17%
Neutrophil Cytoplasmic Antibody
17%
Immunology and Microbiology
Asthma
100%
Complement Factor B
26%
Oxidative Stress
26%
Normal Human
24%
Repressor Gene
22%
Neutrophil
21%
Tumor Necrosis Factor
21%
Neutrophil Granulocyte
20%
Exercise
19%
Chemokine
18%
Cell Death
17%
Bcl-2
17%
Hypoxia Inducible Factor 1
17%
Drug Megadose
17%
Hospital Mortality
17%
Epigenetics
17%
Glucocorticoid
17%
Infection Resistance
17%
Ciclesonide
17%
Defensin
17%
Dynamic Hyperinflation
17%
Bone Density
17%
Hypoxia Inducible Factor
17%
Respiratory Tract Allergy
17%
Nucleic Acid Amplification
17%
Angiopoietin 1
17%
Hemodialysis
17%
Candida
17%
Systemic Inflammation
17%
Budesonide
17%
Drug Sensitivity
17%
Interleukin 6
17%
Interferon Type I
17%
Histone Acetylation
17%
Interleukin 33
17%
Asthma Exacerbation
17%
Mycobacterium Tuberculosis
17%
Circulating Tumor Cell
17%
Epidermal Growth Factor
17%
Granulomatosis with Polyangiitis
17%
Neutrophil Cytoplasmic Antibody
17%
Overall Survival
17%
Exhaled Nitric Oxide
15%
Promoter Region
14%
Mitogen
13%
Inflammatory Cytokine
12%
Forced Expiratory Volume
12%
Agonist
10%
Limb
10%
C-Reactive Protein
10%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
59%
Chronic Obstructive Lung Disease
41%
Nuclear Factor
37%
Alternative Complement Pathway C3 C5 Convertase
37%
Disease
35%
Sleep Disordered Breathing
35%
Anti-Inflammatory Drug
22%
Neoplasm
22%
Pneumonia
21%
Malignant Neoplasm
19%
Endothelin 1
17%
Candidemia
17%
Chronic Cough
17%
Osteosarcoma
17%
Aromatic Hydrocarbon Receptor
17%
2,3,7,8-Tetrachlorodibenzodioxin
17%
Cytoprotective Agent
17%
Respiratory Tract Disease
17%
Solid Malignant Neoplasm
17%
Hospital Mortality
17%
Tumor Necrosis Factor
17%
Histone
17%
Lung Adenocarcinoma
17%
Lipocortin 5
17%
Small Cell Lung Cancer
17%
Cytokine
17%
Mitogen Activated Protein Kinase
17%
Transcription Factor AP 1
17%
Antiinflammatory Agent
17%
Isoniazid
17%
Methacholine
17%
Cytosol Receptor
17%
Epidemic
17%
Provocation Test
17%
Epidermal Growth Factor Receptor
17%
Interferon
17%
Glucocorticoid Receptor
17%
Oxidizing Agent
17%
Ciclesonide
17%
Airway Obstruction
17%
Budesonide
17%
Overall Survival
17%
Inflammation
11%
Histone Acetyltransferase
9%
Fluorodeoxyglucose F 18
8%
Lung Cancer
8%
Hydrogen Peroxide
7%
Vascular Remodeling
7%
Glucocorticoid
5%
Hemodialysis
5%
